127 related articles for article (PubMed ID: 24622733)
1. Specific reactivation of latent HIV-1 with designer zinc-finger transcription factors targeting the HIV-1 5'-LTR promoter.
Wang P; Qu X; Wang X; Zhu X; Zeng H; Chen H; Zhu H
Gene Ther; 2014 May; 21(5):490-5. PubMed ID: 24622733
[TBL] [Abstract][Full Text] [Related]
2. Designed transcription activator-like effector proteins efficiently induced the expression of latent HIV-1 in latently infected cells.
Wang X; Wang P; Fu Z; Ji H; Qu X; Zeng H; Zhu X; Deng J; Lu P; Zha S; Song Z; Zhu H
AIDS Res Hum Retroviruses; 2015 Jan; 31(1):98-106. PubMed ID: 25403229
[TBL] [Abstract][Full Text] [Related]
3. Specific Reactivation of Latent HIV-1 by dCas9-SunTag-VP64-mediated Guide RNA Targeting the HIV-1 Promoter.
Ji H; Jiang Z; Lu P; Ma L; Li C; Pan H; Fu Z; Qu X; Wang P; Deng J; Yang X; Wang J; Zhu H
Mol Ther; 2016 Mar; 24(3):508-21. PubMed ID: 26775808
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional activation of minimal HIV-1 promoter by ORF-1 protein expressed from the SalI-L fragment of human herpesvirus 6.
Kashanchi F; Thompson J; Sadaie MR; Doniger J; Duvall J; Brady JN; Rosenthal LJ
Virology; 1994 May; 201(1):95-106. PubMed ID: 8178493
[TBL] [Abstract][Full Text] [Related]
5. Development of 5' LTR DNA methylation of latent HIV-1 provirus in cell line models and in long-term-infected individuals.
Trejbalová K; Kovářová D; Blažková J; Machala L; Jilich D; Weber J; Kučerová D; Vencálek O; Hirsch I; Hejnar J
Clin Epigenetics; 2016; 8():19. PubMed ID: 26900410
[TBL] [Abstract][Full Text] [Related]
6. Repression of the HIV-1 5' LTR promoter and inhibition of HIV-1 replication by using engineered zinc-finger transcription factors.
Reynolds L; Ullman C; Moore M; Isalan M; West MJ; Clapham P; Klug A; Choo Y
Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1615-20. PubMed ID: 12574502
[TBL] [Abstract][Full Text] [Related]
7. RNA-induced epigenetic silencing inhibits HIV-1 reactivation from latency.
Méndez C; Ledger S; Petoumenos K; Ahlenstiel C; Kelleher AD
Retrovirology; 2018 Oct; 15(1):67. PubMed ID: 30286764
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 reactivation induced by apicidin involves histone modification in latently infected cells.
Lin S; Zhang Y; Ying H; Zhu H
Curr HIV Res; 2011 Jun; 9(4):202-8. PubMed ID: 21631428
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of histone deacetylases: correlation between isoform specificity and reactivation of HIV type 1 (HIV-1) from latently infected cells.
Huber K; Doyon G; Plaks J; Fyne E; Mellors JW; Sluis-Cremer N
J Biol Chem; 2011 Jun; 286(25):22211-8. PubMed ID: 21531716
[TBL] [Abstract][Full Text] [Related]
10. StpC-based gene therapy targeting latent reservoirs of HIV-1.
Turner LS; Tsygankov AY; Henderson EE
Antiviral Res; 2006 Dec; 72(3):233-41. PubMed ID: 16891001
[TBL] [Abstract][Full Text] [Related]
11. Characterization of two candidate genes, NCoA3 and IRF8, potentially involved in the control of HIV-1 latency.
Munier S; Delcroix-Genête D; Carthagéna L; Gumez A; Hazan U
Retrovirology; 2005 Nov; 2():73. PubMed ID: 16305739
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of the basal-level activity of HIV-1 long terminal repeat by HIV-1 nucleocapsid protein.
Zhang JL; Sharma PL; Crumpacker CS
Virology; 2000 Mar; 268(2):251-63. PubMed ID: 10704334
[TBL] [Abstract][Full Text] [Related]
14. NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation.
Williams SA; Chen LF; Kwon H; Ruiz-Jarabo CM; Verdin E; Greene WC
EMBO J; 2006 Jan; 25(1):139-49. PubMed ID: 16319923
[TBL] [Abstract][Full Text] [Related]
15. Repressive LTR nucleosome positioning by the BAF complex is required for HIV latency.
Rafati H; Parra M; Hakre S; Moshkin Y; Verdin E; Mahmoudi T
PLoS Biol; 2011 Nov; 9(11):e1001206. PubMed ID: 22140357
[TBL] [Abstract][Full Text] [Related]
16. CRISPR/gRNA-directed synergistic activation mediator (SAM) induces specific, persistent and robust reactivation of the HIV-1 latent reservoirs.
Zhang Y; Yin C; Zhang T; Li F; Yang W; Kaminski R; Fagan PR; Putatunda R; Young WB; Khalili K; Hu W
Sci Rep; 2015 Nov; 5():16277. PubMed ID: 26538064
[TBL] [Abstract][Full Text] [Related]
17. Role of acetylases and deacetylase inhibitors in IRF-1-mediated HIV-1 long terminal repeat transcription.
Marsili G; Remoli AL; Sgarbanti M; Battistini A
Ann N Y Acad Sci; 2004 Dec; 1030():636-43. PubMed ID: 15659847
[TBL] [Abstract][Full Text] [Related]
18. As2O3 synergistically reactivate latent HIV-1 by induction of NF-κB.
Wang P; Qu X; Wang X; Liu L; Zhu X; Zeng H; Zhu H
Antiviral Res; 2013 Dec; 100(3):688-97. PubMed ID: 24416773
[TBL] [Abstract][Full Text] [Related]
19. Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter.
Lusic M; Marcello A; Cereseto A; Giacca M
EMBO J; 2003 Dec; 22(24):6550-61. PubMed ID: 14657027
[TBL] [Abstract][Full Text] [Related]
20. Hexamethylbisacetamide and disruption of human immunodeficiency virus type 1 latency in CD4(+) T cells.
Choudhary SK; Archin NM; Margolis DM
J Infect Dis; 2008 Apr; 197(8):1162-70. PubMed ID: 18419522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
